Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Long-Term Debt Repayments (2023 - 2025)

Rxo (RXO) has disclosed Long-Term Debt Repayments for 3 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Repayments changed N/A year-over-year to $1.0 million, compared with a TTM value of $3.0 million through Dec 2025, down 97.14%, and an annual FY2025 reading of $2.0 million, down 33.33% over the prior year.
  • Long-Term Debt Repayments was $1.0 million for Q4 2025 at Rxo, down from $2.0 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $101.0 million in Q4 2023 and bottomed at $1.0 million in Q4 2025.
  • Average Long-Term Debt Repayments over 3 years is $26.5 million, with a median of $2.0 million recorded in 2023.
  • Peak annual rise in Long-Term Debt Repayments hit 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
  • Year by year, Long-Term Debt Repayments stood at $101.0 million in 2023, then tumbled by 98.02% to $2.0 million in 2024, then crashed by 50.0% to $1.0 million in 2025.
  • Business Quant data shows Long-Term Debt Repayments for RXO at $1.0 million in Q4 2025, $2.0 million in Q3 2024, and $101.0 million in Q4 2023.